Table 1. Univariate and multivariate Cox regression analysis for the association of ANXA1 staining with TTP.
Univariate | Multivariate | ||||||
---|---|---|---|---|---|---|---|
n of patients | HR | 95% CI | P | HR | 95% CI | P | |
ANXA1 | |||||||
Negative | 272 | 1.00 | 1.00 | ||||
Positive | 45 | 2.99 | 2.14 – 4.16 | < 0.001 | 1.82 | 1.12 – 3.00 | 0.016 |
Age | |||||||
≤ 55 years | 125 | 1.00 | 1.00 | ||||
> 55 years | 192 | 0.59 | 0.47 – 0.75 | < 0.001 | 0.56 | 0.42 – 0.75 | < 0.001 |
Disease-free survival | |||||||
≤ 12 months | 67 | 1.00 | 1.00 | ||||
> 12 months | 250 | 0.69 | 0.52 – 0.91 | 0.008 | 0.72 | 0.51 – 1.01 | 0.057 |
Dominant site of relapse | |||||||
Loco-regional | 43 | 1.00 | |||||
Bone | 113 | 1.20 | 0.83 – 1.74 | 0.235 | |||
Visceral | 74 | 1.27 | 0.85 – 1.89 | 0.238 | |||
Bone and other | 87 | 1.25 | 0.85 – 1.84 | 0.258 | |||
PgR* | |||||||
Negative | 111 | 1.00 | 1.00 | ||||
Positive | 204 | 0.51 | 0.40 – 0.64 | < 0.001 | 0.71 | 0.52 – 0.97 | 0.034 |
Her2 status* | |||||||
Negative | 201 | 1.00 | |||||
Positive | 114 | 1.18 | 0.93 – 1.50 | 0.170 | |||
Tumor differentiation* | |||||||
Good | 46 | 1.00 | 1.00 | ||||
Moderate | 150 | 1.45 | 1.01 – 2.06 | 0.042 | 1.15 | 0.79 – 1.67 | 0.456 |
Poor | 118 | 1.95 | 1.35 – 2.82 | < 0.001 | 1.24 | 0.82 – 1.89 | 0.311 |
Missing data not reported.
Tumor differentiation was assessed through Bloom-Richardson scoring system.
Acronym: PgR: progesterone receptor.